The 5 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 7.00, with a high estimate of 23.00 and a low estimate of 2.50. The median estimate represents a +76.32% increase from the last price of 3.97.
The current consensus among 6 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Feb 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.